Therapy, diagnosis and prognosis of chronic Chagas disease: insight gained in Argentina
Open Access
- 1 July 2009
- journal article
- review article
- Published by FapUNIFESP (SciELO) in Memórias do Instituto Oswaldo Cruz
- Vol. 104 (suppl 1) , 167-180
Abstract
The purpose of this review is to describe research findings regarding chronic Chagas disease in Argentina that have changed the standards of care for patients with Trypanosoma cruzi infection. Indirect techniques (serological tests) are still the main tools for the primary diagnosis of infection in the chronic phase, but polymerase chain reaction has been shown to be promising. The prognosis of patients with heart failure or advanced stages of chagasic cardiomyopathy is poor, but a timely diagnosis during the initial stages of the disease would allow for prescription of appropriate therapies to offer a better quality of life. Treatment of T. cruzi infection is beneficial as secondary prevention to successfully cure the infection or to delay, reduce or prevent the progression to disease and as primary disease prevention by breaking the chain of transmission. Current recommendations have placed the bulk of the diagnostic and treatment responsibility on the Primary Health Care System. Overall, the current research priorities with respect to Chagas disease should be targeted towards (i) the production of new drugs that would provide a shorter treatment course with fewer side effects; (ii) the development of new tools to confirm cure after a full course of treatment during the chronic phase and (iii) biomarkers to identify patients with a high risk of developing diseases.Keywords
This publication has 84 references indexed in Scilit:
- Pediatric Clinical Pharmacology Studies in Chagas DiseasePediatric Drugs, 2009
- Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas diseaseNature Medicine, 2008
- Serological Evaluation of Specific-Antibody Levels in Patients Treated for Chronic Chagas' DiseaseClinical and Vaccine Immunology, 2008
- Evaluation of Serological Tests To Identify Trypanosoma cruzi Infection in Humans and Determine Cross-Reactivity with Trypanosoma rangeli and Leishmania sppClinical and Vaccine Immunology, 2007
- Usefulness of PCR Strategies For Early Diagnosis of Chagas' Disease Reactivation and Treatment Follow-Up in Heart TransplantationAmerican Journal of Transplantation, 2007
- The Anti-Trypanosoma cruziActivity of Posaconazole in a Murine Model of Acute Chagas' Disease Is Less Dependent on Gamma Interferon than That of BenznidazoleAntimicrobial Agents and Chemotherapy, 2007
- Detection of parasitemia profiles by blood culture after treatment of human chronic Trypanosoma cruzi infectionParasitology Research, 2006
- The Need of a Neonatal Preparation for Chagas DiseasePLOS Medicine, 2005
- Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditisAmerican Heart Journal, 1984
- Chagasic CardiopathyCirculation, 1974